Atlas FDA

Predicate Research Report · generated 2026-08-23 · Print / save as PDF · Save to account

Zhejiang Curaway Medical Technology Co., Ltd. · Predicate Candidate Screening

6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

266 daysmedian FDA review time
336 days90th percentile
6clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K244018Disposable Biopsy NeedleZhejiang Curaway Medical Technology Co., Ltd.2025-07-222070
K241793Automatic Core Biopsy Instrument/ Semi-Automatic Core BiopsyZhejiang Curaway Medical Technology Co., Ltd.2025-01-242170
K242322Bone Marrow Biopsy NeedleZhejiang Curaway Medical Technology Co., Ltd.2025-01-241710
K240758Radiofrequency Generator System, Cura RF ElectrodeZhejiang Curaway Medical Technology Co., Ltd.2024-12-112660
K232505Endovenous Radiofrequency Generator, Endovenous RadiofrequenZhejiang Curaway Medical Technology Co., Ltd.2024-05-302860
K222001Irreversible Electroporation Ablation Generator, IrreversiblZhejiang Curaway Medical Technology Co., Ltd.2023-06-083360

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda